AbSci Raises Series B Financing

AbSci Raises Series B Financing

AbSci, a global leader in breakthrough biomanufacturing technologies, announced that it closed its Series B financing round for an undisclosed amount. The round includes previous investors along with several new investors …

AbSci Secures Series A Funding

PORTLAND, Ore., April 25, 2016 /PRNewswire/ — AbSci, a global leader in soluble microbial protein expression has secured $5.1M in Series A financing led by Phoenix Venture Partners (PVP). Funding will accelerate commercialization of AbSci’s...